Treatment of embolic stroke as a medical emergency: Implications in a managed care environmentEncouraging innovations should be a concern of the providers/gatekeepers of health-care if lower health-care costs are to become a reality. Controlled prices and improper incentives will dramatically slow ...
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke Background: Whether closure of a patent foramen ovale reduces the risk of recurrence of ischemic stroke in patients who have had a cryptogenic ischemic stroke is unknown.Methods: In a multicenter, randomized, open-...
In this study, we aimed to investigate the role of the described markers of endothelial pathology as indicators of atrial cardiopathy and fibrillation in ESUS. The patients considered in our previous work have been followed up at least one year after index stroke to investigate the long-term temp...
Background Tandem proximal and distal occlusions in the setting of an acute stroke are therapeutic challenges. Treating either lesion first has its respect... Ferdinand,K,Hui,... - 《Journal of Neurointerventional Surgery》 被引量: 12发表: 2011年 Embolic protection device use and its association...
Alteplase (tissue plasminogen activator, tPA) is currently the only FDA-approved treatment that can be given to acute ischemic stroke (AIS) patients, if patients present within 3 h of an ischemic stroke. Recent clinical trial evidence now suggests th
There was a thrombo-embolic event following the deployment of the LEO stent in one patient with acute subarachnoid hemorrhage, whom was cured without ... JB Zhang,LI You-Xiang,WU Zhong-Xue - 《Chinese Journal of Stroke》 被引量: 0发表: 2009年 The SMART Registry: Long-Term Results on the...
P Petersen,J Godtfredsen - 《Stroke》 被引量: 625发表: 1986年 Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation The medical records of 254 patients with atrial fibrillation were reviewed to determine the incidence of embolic events in relation to ...
Altogether, our study demonstrates that GPH has many advantages over the currently used embolic agents and has potential applications in clinical practice. Similar content being viewed by others Molecularly self‐fueled nano-penetrator for nonpharmaceutical treatment of thrombosis and ischemic stroke ...
such as requiring delivery of multiple coils with a 1.4–2.7% chance of rupture of the aneurysm with every delivered coil [1], post-operative coil compaction [3], and shifting or even migration of the coils out of the aneurysm [4], causing risks of aneurysm regrowth or rupture/stroke. I...
Most often, systemic embolization occurs in IE, affecting the valves on the left side of the heart, and can lead to stroke, splenic infarction, renal infarction, limb ischemia, or acute myocardial infarction if septic emboli occlude coronary arteries [9]. Less common in terms of IE ...